ValoreQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMSpese di vendita, generali e amministrative761 M703 M718 M708 M761 M2.89 BRicerca e sviluppo211 M140 M134 M118 M126 M518 MReddito operativo-435 M58 M191 M172 M-729 M-308 MProventi non operativi, Totale3 M5 M-13 M6 M31 M29 MOneri finanziari, al netto degli interessi capitalizzati113 M81 M-14 M-10 M113 M—Proventi non operativi, esclusi gli oneri finanziari-114 M-79 M1 M9 M-113 M-182 MEntrate/uscite straordinarie4 M3 M07 M31 M41 MUtile al lordo delle imposte-521 M-3 M133 M121 M-756 M-505 MQuota di utile——————Imposte-33 M-67 M11 M172 M279 M395 MInteressi di minoranza2 M00000Altri proventi/oneri al netto delle imposte-21 M-6 M-14 M-2 M-8 M-30 MUtile netto al lordo delle attività cessate-490 M64 M122 M-51 M-1.03 B-900 MAttività cessate-22 M62 M-31 M5 M-93 M-57 MUtile netto-512 M126 M91 M-46 M-1.13 B-957 MRegolazione della diluizione——————Dividendi privilegiati——————Utile netto diluito attribuibile agli azionisti ordinari-512 M126 M91 M-46 M-1.13 B-957 MUtile base per azione (EPS base)-10.250.18-0.09-2.21-1.87Utile diluito per azione (EPS diluito)-10.250.18-0.09-2.21-1.87Numero medio di azioni ordinarie in circolazione510 M512 M513 M514 M513 M2.05 BAzioni diluite in circolazione510 M514 M514 M514 M513 M2.06 BEBITDA-953 M69 M227 M180 M-1.61 B-1.14 BEBIT-1.2 B-178 M-30 M-57 M-1.85 B-2.12 BCosto del fatturato1.79 B1.76 B1.82 B1.89 B2.4 B7.87 BAltri costi del venduto——————Ammortamento e svalutazione (liquidità)245 M247 M257 M237 M240 M981 M
Baxter International Inc
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals.
Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients.
Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services".
Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology.